• 6th LAC Abstracts - Financial Disclosure Statements

    Oct 1, 2017, 00:00

  • Misclassification of Diabetes Type I in German Claims Data

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Potential Combined Vaccine Against Lyme Borreliosis And Tick-Borne Encephalitis In Slovenia

    Oct 1, 2017, 00:00

  • Interrupted Time Series Analysis Evaluating The Impact of A Pro-Generic Policy on Drug Pricing and Utilization In Argentina

    Oct 1, 2017, 00:00

  • Psychological Impact of Cancer- More Good than Bad

    Oct 1, 2017, 00:00

  • Spatial Dynamics Of Psychiatric Disease Hospitalized Patients - Rehospitalization Simulation Focussing On Diabetes Comorbidity And Regional Health Services In Three European Regions Over The Next Decades

    Oct 1, 2017, 00:00

  • Insight Into the Role of the General Practitioner in the Management of Colorectal Cancer- Record Linkage of the Netherlands Cancer Registry and the General Practitioner Database of the Pharmo Database Network

    Oct 1, 2017, 00:00

  • Real World Evidence (RWE) on Long-Term Persistence of Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) in Australia

    Oct 1, 2017, 00:00

  • Affordability and WTP Challenges of Combinations of High Value/High Priced Products In Oncology – Identifying Solutions for Immunotherapies, Precision Medicines, and Anti-Body Drug Conjugates

    Oct 1, 2017, 00:00

  • Health Technology Assessment In Singapore- Shining A Light In The Darkness

    Oct 1, 2017, 00:00

  • Are Patient Outcomes Being Relegated By Nices Budget Impact Test?

    Oct 1, 2017, 00:00

  • Detrimental Impact of Toxicity on Quality of Life In Hepatocellular Carcinoma Patients Treated with Lenvatinibor Sorafenib

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Vancomycin And Linezolid- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Health Insurance Cost of Psychotic Disorders In Hungary- A Cost of Illness Study

    Oct 1, 2017, 00:00

  • Health Care Resource Utilization And Costs Associated With HIV-Positive Patients With Comorbidity Versus HIV-Negative Patients With Comorbidity

    Oct 1, 2017, 00:00

  • Budget Impact of The Inclusion of Oxycodone In The Brazilian Public Healthcare Setting For The Treatment of Cancer Pain

    Oct 1, 2017, 00:00

  • Influence of Peer Pressure Mechanism on Quality and Costs of Healthcare, on Examples of Israel, France and USA

    Oct 1, 2017, 00:00

  • Analysis Of Pharmacy Claims For High Cost Drugs- Ruxolitinib Utilisation And Expenditure In Ireland

    Oct 1, 2017, 00:00

  • Assessment and Comparison of National and International Regulations On Registration Of Biosimilars

    Oct 1, 2017, 00:00

  • Landscape of Malignant Melanoma- The Impact of Upcoming Therapies

    Oct 1, 2017, 00:00

  • Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Compras De Medicamentos Sem Licitação No Instituto Nacional De Câncer Do Brasil

    Oct 1, 2017, 00:00

  • Modelo Económico De Estimación De Gasto Farmacéutico En UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Opioid Use Outcomes Among Female Breast Cancer Patients Using Adjuvant Endocrine Therapy Regimens

    Oct 1, 2017, 00:00

  • The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic

    Oct 1, 2017, 00:00

  • The Implementation Of Robotic-Assisted Surgery For Endometrial Cancer In The United States Lead To An Improvement Of Overall 30-Day Surgical Outcomes Without Increasing Costs- Is Technology Finally Allowing The Diffusion Of Minimally Invasi ...

    Oct 1, 2017, 00:00

  • Risk of Major Osteoporotic Fracture (Hip, Vertebral, Radius, Humerus [MOF]) After First, Second and Third Fragility Fracture In A Swedish General Population Cohort

    Oct 1, 2017, 00:00

  • Early Acess But Then What? The Uk Early Access To Medicines Scheme Three Year Report Card

    Oct 1, 2017, 00:00

  • A Validation Study of The Rank-Preserving Structural Failure Time Model- Confidence Intervals, Unique, Multiple and Erroneous Solutions

    Oct 1, 2017, 00:00

  • Effects of Low Salt Diet on Gene Expression in Dog Heart

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil

    Oct 1, 2017, 00:00

  • Assessment of Isoniazid Prophylaxis Therapy Initiation Appropriateness, Adverse Drug Reaction and Adherence Among Hiv Patients In University of Gondar Referral Hospital, Northwest Ethiopia

    Oct 1, 2017, 00:00

  • BRCA1/2-Mutated Breast Cancer In Select EU Markets- Incidence, Treatable Populations, And Potential Market Size For Parp Inhibitors

    Oct 1, 2017, 00:00

  • Will Prioritization of Vaccine Introduction Lead to a Higher Return of Investment? The Case of Colombia

    Oct 1, 2017, 00:00

  • Assessing Comparability and Patient Profile of Two Claims Databases in Oncology in Brazil

    Oct 1, 2017, 00:00

  • Pharmacoeconomics of Certolizumab Pegol- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Translation And Cultural Adaptation Of The Body-Q Chest Module Into Finnish For Use In Gynecomastia, Weight Loss And FTM Chest Surgery

    Oct 1, 2017, 00:00

  • Denied Oncology Treatment Claims- How Much Do They Cost and How Can we Prevent Resource Waste?

    Oct 1, 2017, 00:00

  • A Comprehensive Assessment of The HTA Landscape For Reimbursement of Rheumatoid Arthritis Drugs- Pitfalls and Challenges In Gaining Successful Approvals

    Oct 1, 2017, 00:00

  • Systematic Review on Clinical Outcomes of Ultrasonic Technology For Patients Undergoing Gyn Oncology Procedures

    Oct 1, 2017, 00:00

  • Haart Treatment Trends In Hiv/Aids Patients In A Tertiary Care Hospital, Malaysia

    Oct 1, 2017, 00:00

  • The French Compassionate Program "Temporary Authorization For Use" And Thereafter... How Can It Affect Drug Market Access?

    Oct 1, 2017, 00:00

  • Análisis Multicriterio Del Uso De Dos Líquidos Dializantes Para Hemodiálisis En Perú

    Oct 1, 2017, 00:00

  • Clinical Inertia in Type 2 Diabetes Mellitus- Time in Poor Glycaemic Control Until Treatment Intensification in Patients on DPP-4I And/Or SGLT-2I Treatment

    Oct 1, 2017, 00:00

  • Add-On Therapy in Breast Cancer - Probability of Cost-Effectiveness in Economic Analyses

    Oct 1, 2017, 00:00

  • Epidemiology and Outcomes of Different Treatment Strategies In Patients With Pneumonia Caused By Carbapenem-Resistant Acinetobacter Baumnnii In Medical Intensive Care Units

    Oct 1, 2017, 00:00

  • Economic Evaluation of Flash Glucose Monitoring Compared To Self - Monitoring of Blood Glucose For The Management of Patients Receiving Intensive Insulin With Diabetes Type 1 And Type 2 In Greece

    Oct 1, 2017, 00:00

  • The Disease Burden of Heart Failure in Portugal

    Oct 1, 2017, 00:00

  • Estimations of Resource use, Costs, Clinical and Epidemiological Outcomes of Continuous and Intermittent Renal Replacement Therapies

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Bariatric Surgery In Turkey- From A Long-Term Perspective

    Oct 1, 2017, 00:00

  • Real-World Health-Related Quality of Life Eq-5d-5l Outcomes In Ankylosing Spondylitis (AS)- Analysis of Data From The Uk British Society For Rheumatology Register In Ankylosing Spondylitis (BSRBR-AS) Study

    Oct 1, 2017, 00:00

  • Health Insurance Perspective and Collective Perspective- The Differences In The Collection and Valuation of Cost Data In France

    Oct 1, 2017, 00:00

  • The Flow Of EU-28 Country Clusters In Terms Of Infectious And Chronic Diseases During A Refugee Crisis

    Oct 1, 2017, 00:00

  • Idelvion For The Treatment of Hemophilia B- A Budget Impact Analysis In The Italian Setting

    Oct 1, 2017, 00:00

  • Adherence Issues In Rheumatoid Arthritis Treatment- How Can Acceptance Measurement Help Understanding Patients’ Concerns And Working on Solutions?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients With Chronic Phase- Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of P4HB VS Permanent Synthetic Meshes In Complex Abdominal Wall Repair In Spain

    Oct 1, 2017, 00:00

  • Understanding Mortality In Multiple Myeloma (MM)- Findings From An Observational Chart Review of Deceased Patients In The UK, France, Germany, Italy And Spain

    Oct 1, 2017, 00:00

  • Does Ccg Spending on Cancer Affect Outcomes in Breast and Lung Cancer?

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Deep Brain Stimulation For The Treatment Of Parkinson’s Disease Patients In The Italian Setting

    Oct 1, 2017, 00:00

  • The Role Of Patient Groups In Nice Technology Appraisals For Drugs For Rare Diseases

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Nivolumab for Patients with Advanced, Previously Treated Renal Cell Carcinoma in Scotland

    Oct 1, 2017, 00:00

  • The Effect of Policies for Improving the Access to New Medicines in South Korea- A Retrospective Analysis in 2007 - 2016

    Oct 1, 2017, 00:00

  • Clinical and Economic History of The Oncological Patient At The End of Life

    Oct 1, 2017, 00:00

  • No EQ-5D? Analysis of Alternative Utility Value Sources Used in Nice Appraisals for Oncology Indications

    Oct 1, 2017, 00:00

  • Exploring The Burden of Illness and Impact of SQ-Standardised Grass Allergy Immunotherapy Tablet Treatment (AIT) on Quality of Life (QOL) in Patients with Allergic Rhinitis (AR) in Germany and The Netherlands

    Oct 1, 2017, 00:00

  • The Prescription Pattern and Prevalence of Psoriasis in a Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Sequential Treatment Containing Crizotinib for Non Small Cell Lung Cancer (ALK+) Patients

    Oct 1, 2017, 00:00

  • Treatment Of Postpartum Depression- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Empirical Studies On The Economic Value Of A Statistical Life Year (VSLY) In Europe- What Do They Tell US?

    Oct 1, 2017, 00:00

  • Quimioterapia Do Câncer Nas Últimas Semanas De Vida- Estudo Retrospectivo Em Beneficiários De Um Plano De Saúde Privado No Brasil

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis Of Shortened Direct-Acting Antiviral Treatment For Mild Chronic Hepatitis C Virus

    Oct 1, 2017, 00:00

  • Assessment of Patients Admitted For Drug-Related Problems In Cancer Chemotherapy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Apixaban And Rivaroxaban For Treatment of Acute Venous Thromboembolism In China

    Oct 1, 2017, 00:00

  • Evaluation of Health Care Reform Impact on Cancer Patients` Total out of Pocket- A Pilot-Center Experience in Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Overall Survival In Patients With Non-Small Cell Lung Cancer- A Comparison Of Clinical Trial Versus Real-World Outcomes Using A Propensity Score Reweighting Approach

    Oct 1, 2017, 00:00

  • Orphan Drug Reimbursement In Europe- Do Less Stringent Regulatory Requirements Translate Into Less Favourable Reimbursement?

    Oct 1, 2017, 00:00

  • Pulmonary Tuberculosis Trends and Treatment Outcomes In The Gomoa West District,Ghana

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Adding New Drug Thiozonide To Iv-Th Drug Regimens For Multidrug-Resistant Tuberculosis

    Oct 1, 2017, 00:00

  • Expanded Access To Pembrolizumab from Cost-Savings Generated by Biosimilar Filgrastim (BIOSIM-FIL) in The Prophylaxis of Chemotherapy-Induced (FEBRILE) Neutropenia (CIN/FN)- Simulation Study

    Oct 1, 2017, 00:00

  • Close HER2 Home- Breast Cancer Patients Preferences For Treatment Delivery

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Mexico

    Oct 1, 2017, 00:00

  • Estimating Utilities / Disutilities for High Risk Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) and Treatment-Related Adverse Events

    Oct 1, 2017, 00:00

  • Evaluation Of Resource Utilization Among Infants, Young Children And Elderly Patients Diagnosed With Rsv Infection In The United States

    Oct 1, 2017, 00:00

  • Patient Characteristics of Premix Insulin Users in China- An Analysis of Electronic Medical Record Data

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Venetoclax In View of A Clinical Trial With No Control Group

    Oct 1, 2017, 00:00

  • Resource Utilization And Disaggregated Cost Analysis For Initial Treatment Of Melanoma

    Oct 1, 2017, 00:00

  • Clinical Effectiveness of Smoking Cessation Therapy During Pregnancy

    Oct 1, 2017, 00:00

  • Characterization Of Worldwide Publications On Network Meta-Analysis- A Systematic Review

    Oct 1, 2017, 00:00

  • Comparison of The Reimbursement Decisions of Pharmaceuticals In Hungary, Romania And Turkey

    Oct 1, 2017, 00:00

  • Costo De La Atención De La Enfermedad De Crohn En Un Centro Asistencial De Bogotá, Colombia

    Oct 1, 2017, 00:00

  • Effectiveness of Surgical Stabilization of Rib Fractures with or without Flail Chest – A Systematic Review

    Oct 1, 2017, 00:00

  • Comparative Effectiveness And Safety Of Medical Abortion For Second-Trimester Pregnancy Termination- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Trifluridine and Tipiracil Hydrochloride In The Treatment of Metastatic Colorectal Cancer in Greece

    Oct 1, 2017, 00:00

  • Review Of Published Health-Economic Appraisals By The Haute Autorite De Sante (HAS) In Advanced Melanoma

    Oct 1, 2017, 00:00

  • Financiamiento Del Cribado Y Tratamiento De La Nefropatía Diabética En El Primer Nivel De Atención Por El Seguro Integral De Salud, Perú

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Community Pharmacists' Intervention For Patients With Type 2 Diabetes In Prevention of Diabetic Retinopathy

    Oct 1, 2017, 00:00

  • The Association Between Disease Activity and Health-Related Quality of Life in RRMS Patients

    Oct 1, 2017, 00:00

  • Determinants Of Herpes Zoster Vaccine Acceptability Among Older People In The UK

    Oct 1, 2017, 00:00

  • Life Expectancy And Costs of Transthyretin Familial Amyloid Polyneuropathy

    Oct 1, 2017, 00:00

  • Patient-Reported Outcome Measures for Women with Vulvodynia

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer Patients. Preliminary Results From Colombia

    Oct 1, 2017, 00:00

  • Determinants Of The Optimal Route To Reimbursement For Orphan Medicinal Products (OMPS) In England

    Oct 1, 2017, 00:00

  • Subcutaneous vs Intravenous Administration of Trastuzumab in Her2+ Breast Cancer Patients- A Montenegrin Cost-Minimization Analysis

    Oct 1, 2017, 00:00

  • Key Factors Resulting In Differential Reimbursement Decisions Between The National Institute For Health And Care Excellence (NICE) And The Scottish Medicines Consortium (SMC) For Medicines Authorised By The European Medicines Agency (EMA) T ...

    Oct 1, 2017, 00:00

  • Barriers To Management of Diabetic Eye Diseases In Turkey- Dr Barometer Survey

    Oct 1, 2017, 00:00

  • Comparison of Low-Dose Liraglutide Use Versus other GLP-1 Receptor Agonists In Patients Without Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Investing In Skilled Specialists To Grow Hospital Infrastructure And Improve Quality

    Oct 1, 2017, 00:00

  • A Retrospective Analysis Of The Role Of (Economic) Evidence In Decision Making- The Introduction Of HPV Vaccination In The Netherlands

    Oct 1, 2017, 00:00

  • Evaluating Patients’, Physicians’ And Pharmacists’ Perception Regarding Generic Medicines In Ethiopia- Findings And Implications

    Oct 1, 2017, 00:00

  • Trabectedin Versus Pazopanib within The Treatment of Advanced, Metastatic, Leiomyosarcomas in Scotland- Results of A Cost-Effectiveness Analysis Following A Matching Adjusted Indirect Comparison

    Oct 1, 2017, 00:00

  • The Attitude Of Polish Physicians Towards Introduction Of E-Prescription – A Questionnaire Survey

    Oct 1, 2017, 00:00

  • Costs of Adding Sitagliptin or Sulphonylurea To Metformin- An Observational Study Using Administrative Database of Italy

    Oct 1, 2017, 00:00

  • Heterogeneity In GP Consultation Costs In Health Technology Assessments- Explanations And Implications

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Insulin Degludec U100 Compared With Insulin Glargine U100 In Greece

    Oct 1, 2017, 00:00

  • Characterization Of Health Care Utilization And Cost Of Hemophilia A And B In Real-Life- A 4-Year Follow-UP Study In Finland

    Oct 1, 2017, 00:00

  • Costo De La Inmunización De Rutina En Menores De Un Año En El Año 2016 En El Ecuador

    Oct 1, 2017, 00:00

  • International Reference Pricing Expands Reach in Leading Latin American Countries

    Oct 1, 2017, 00:00

  • Regulatory Reimbursement Decisions Database for Innovative Drugs to Improve Consistency of Decision-Making

    Oct 1, 2017, 00:00

  • Replicating The Medication Adherence Reasons Scale (Mar-Scale) Factor Structure In People Using Daily Orals For Depression, Gastroesophageal Reflux Disease, Rheumatoid Arthritis, And Epilepsy

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Contour Curved Cutter Stapler In Low Anterior Resection In Turkey

    Oct 1, 2017, 00:00

  • Effect of Multiple Sclerosis on Work Productivity

    Oct 1, 2017, 00:00

  • The Changing Trend of Cardiovascular Disease And Its Clinical Characteristics In Ethiopia-Hospital-Based Observational Study

    Oct 1, 2017, 00:00

  • An Analysis of The Current Jordanian Pricing System and Developing Recommendations for Its Enhancemnet

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Obinutuzumab Associated to Chlorambucil for the Treatment of Slow-Go Patients with Chronic Lymphocytic Leukemia (CLL) Under the Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Patient Preferences In Italy- Health State Utilities Associated With Attributes Of Weekly Injection Devices For Treatment Of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • One Year Report Card For The Cancer Drugs Fund Reforms – From Absurdity To Irrelevance?

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Low-Dose Methoxyflurane For The Treatment of Moderate-To-Severe Trauma Pain In Sweden

    Oct 1, 2017, 00:00

  • The Importance Of The Disinvestment Process In The Public Health System

    Oct 1, 2017, 00:00

  • Search Of High Active And Low Toxic Newly Synthesized Derivatives Of Piperidine For Regional Anesthesia

    Oct 1, 2017, 00:00

  • Decision Making Clinical Scenarios As A Tool In HTA Process

    Oct 1, 2017, 00:00

  • Deep Brain Stimulation For Parkinson's Disease- Comparison Between Unilateral And Bilateral Implantation

    Oct 1, 2017, 00:00

  • Transition From Orphan Disease To Full Assessment In The German Amnog System- Key Learnings From Pioneers

    Oct 1, 2017, 00:00

  • Price Analysis of HIV Antiretroviral Drugs Marketed In The United States (1987-2015)

    Oct 1, 2017, 00:00

  • The Association Hemoglobin Levels with Health-Related Quality of Life of Patients with Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Impact Of Multi-Drug Resistance On HTA Assessment Of Antibiotics In France, Germany, United Kingdom

    Oct 1, 2017, 00:00

  • The Cost Of Illness Of Heart Failure In Portugal

    Oct 1, 2017, 00:00

  • A Real World Evidence (RWE) Approach To Characterising An Ultra-Rare Disease (URD) Cohort of Metastatic Uveal Melanoma (MUM) Patients Within National Health Service England (NHSE)

    Oct 1, 2017, 00:00

  • The Effect Of Epilepsy On The Bulgarian Patients – Pilot Study

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Argentina

    Oct 1, 2017, 00:00

  • What Impact Does Nice’s Modified Cancer Drugs Fund Process Mean For Patient Access To New Oncology Pharmaceuticals In England?

    Oct 1, 2017, 00:00

  • Medication Adherence and Risk of Hospitalization in Pulmonary Arterial Hypertension (PAH) Patients Treated with Endothelin Receptor Antagonists (ERAS) or Phosphodiesterase Type 5 Inhibitors (PDE5IS)

    Oct 1, 2017, 00:00

  • Hierarchical Bayesian Model Accounts For Heterogeneity In Oncologists’ Stated Preference On Various Breast Cancer Treatments

    Oct 1, 2017, 00:00

  • Patient Empowerment for Healthcare Decision-Making Assessing Oncology Innovation Through Multicriteria Decision Analysis

    Oct 1, 2017, 00:00

  • Predicting EQ-5D Index Scores From Promis Profile 29 In The United Kingdom, France, And Germany

    Oct 1, 2017, 00:00

  • Effects of Improved Detection And Treatment of Atrial Fibrillation On Burden of Disease Caused By Stroke In Germany

    Oct 1, 2017, 00:00

  • Statin Cost Effectiveness- A Systematic Review Including The Recent Literature

    Oct 1, 2017, 00:00

  • The French Compassionate Use Of Medicinal Products Programme- A Drastic Increase Of Expenditure Over The 2012-2016 Period

    Oct 1, 2017, 00:00

  • The Association Between Multimorbidity And Subjective Health Status- Mediating Effect Of Activities Of Daily Livings

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Costa Rica

    Oct 1, 2017, 00:00

  • Access And Reimbursement For Emerging Neuropathic Pain Agents In The EU5- Avoiding The Sting Of Low-Cost Competition And Tightening Budgets

    Oct 1, 2017, 00:00

  • Patients’ Information Sources and Needs in Multiple Sclerosis- the Infoseek-MS Questionnaire

    Oct 1, 2017, 00:00

  • Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System

    Oct 1, 2017, 00:00

  • Randomized Controlled Trial Evaluating the Effectiveness of Pictogram Intervention in Identification and Reporting Adverse Drug Reactions in Naïve Hiv Patients in Ethiopia

    Oct 1, 2017, 00:00

  • Cost Utility Analysis (CUA) of Nivolumab Compared To Everolimus for The Treatment of Metastatic Renal Cell Carcinoma (RCC) in Australia

    Oct 1, 2017, 00:00

  • Number of Visits Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • A Critical Quality Appraisal Of Studies Estimating The Cost Of Radiotherapy

    Oct 1, 2017, 00:00

  • Rates Of Uptake Of Novel Agents In Cancer (Prostate, Melanoma, And Lung)- Considerations For Forecasting In Economic Evaluations

    Oct 1, 2017, 00:00

  • Budget Impact Of Introducing Ceftazidime-Avibactam (CAZ-AVI) For Complicated Intra-Abdominal Infection (CIAI), Complicated Urinary Tract Infections (CUTI), And Hospital Acquired Pneumonia Including Ventilator-Associated Pneumonia (HAP/VAP) ...

    Oct 1, 2017, 00:00

  • Funding New Technologies in German Inpatient Care - Does it Work?

    Oct 1, 2017, 00:00

  • Qualitative Research Methods For Collecting, Analyzing, And Presenting Patient-Reported Data On Noticeable And Important Change In Disease-Related Signs And Symptoms

    Oct 1, 2017, 00:00

  • Financiamiento De Enfermedades Huérfanas Y Raras EN Latinoamérica

    Oct 1, 2017, 00:00

  • Vaccine Efficacy, Effectiveness, Or Impact- Which One To Choose In Economic Evaluations Of Vaccines?

    Oct 1, 2017, 00:00

  • F-Calprotectin Use In Inflammatory Bowel Disease Is Characterised By Improved Diagnostic Accuracy, Less Patient Harm And Decreased Costs, Compared With Conventional Serological Markers And Colonoscopy. A Simulation Study In The Netherlands ...

    Oct 1, 2017, 00:00

  • Evaluation Of An Attitudes Toward Medical Errors Scale In Pharmacy And Healthcare Professional Students

    Oct 1, 2017, 00:00

  • A Systematic Literature Review On Quality Of Life And Economic Burden Of Psoriasis In The Asia-Pacific Region

    Oct 1, 2017, 00:00

  • Methodological Issues With Key Drug Value Frameworks

    Oct 1, 2017, 00:00

  • An Audit of Evidence Review Group Criticisms of Systematic Literature Reviews Conducted To Inform Manufacturers' Submissions To The National Institute for Health and Care Excellence

    Oct 1, 2017, 00:00

  • The Effect of Value Based Insurance Designs on Costs- A Systematic Review

    Oct 1, 2017, 00:00

  • Living With Chronic Diseases In Gree Investigating Health Services Utilization Patterns And Economic Consequences

    Oct 1, 2017, 00:00

  • Use of Brentuximab Vedotin to Treat Hodgkin Lymphoma in a Private Sector Setting in Brazil

    Oct 1, 2017, 00:00

  • Economic Evaluation for The Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) From The NHS Perspective- A Spending Predictor Model for Italy, Romania and Spain

    Oct 1, 2017, 00:00

  • Differences And Decision Drivers In The Hta-Outcome Category Lower Benefit Between Iqwig And G-Ba Assment In The German Amnog Process

    Oct 1, 2017, 00:00

  • Potenciales Ahorros De La Implementación De La Prueba Dímero D (Point of Care) EN LA Atención De Primer Contacto De Pacientes Con Sospecha De Trombosis Venosa

    Oct 1, 2017, 00:00

  • INCORPORATION OF NEW MEDICINES BY THE BRAZILIAN HEALTHCARE SYSTEM´S NATIONAL COMMITTEE FOR HEALTH TECHNOLOGY INCORPORATION, 2012 TO JUNE/2016

    Oct 1, 2017, 00:00

  • Using A "Landmark" Approach To Artificially Populate The Comparator Arm Of An Economic Model Using Data From A Phase II, Uncontrolled Trial In Advanced Basal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Impact of Cytomegalovirus Infection and Treatment on Patient-Reported Outcomes In Haematopoietic Cell Transplant Recipients

    Oct 1, 2017, 00:00

  • Burden of Cardiovascular Disease (CVD) For Patients With Familial Hypercholesterolemia (FH) Or Atherosclerotic CVD (ASCVD) And The Impact Of Low Density Lipoprotein-Cholesterol (LDL-C) Lowering In Two Middle East Countries

    Oct 1, 2017, 00:00

  • The Role Of Medical Technologies In Revolutionising The NHS In England- A Review Of Sustainability And Transformation Plans (STPS)

    Oct 1, 2017, 00:00

  • Inhibitors of Tirosin Kinasa in Chronic Mieloid Leukemia- Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Table of Contents

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Flash Glucose Monitoring System Based On Real-World Usage For Type 1 Diabetes (T1DM) Patients Using Intensive Insulin- A Swedish Perspective

    Oct 1, 2017, 00:00

  • Launching Combination Therapies In Rare Diseases- Is High Cost Burden Restricting Access?

    Oct 1, 2017, 00:00

  • Therapeutic Reference Pricing System Cost-Saving Ability And Its Impact On Patient Out-Of-Pocket Expenses In Slovenia

    Oct 1, 2017, 00:00

  • Evaluation of the Cost Effectiveness of the Treatment of Mild and Moderate Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Real World Characteristics and Perceived Efficacy of Peginterferon Beta-1A Compared with Other Platform Injectable Therapies Among MS Patients- Evidence in Five European Countries

    Oct 1, 2017, 00:00

  • Indicators to Evaluate Hiv Prevention in Colombian Health System

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Effectiveness of the Inclusion of Glycopyrronium Bromide into the Program of Reimbursement of Essential Drugs for Patients with COPD

    Oct 1, 2017, 00:00

  • Cost Assessment Of Acquired Resistant Bacterial Infection In A Hospital In The Dominican Republic

    Oct 1, 2017, 00:00

  • Orthognacthic Surgery in Brazil- Mapping the Variability in Requested Matherials Using Real-World Data

    Oct 1, 2017, 00:00

  • Health Economics Evidence in Peer-Reviewed Journals- Increase in Reporting of Real-World Data Over Time in Type 2 Diabetes

    Oct 1, 2017, 00:00

  • The Short Term Health Related Quality Of Life (HRQOL) Impact On Patient At The Internal Medicine Clinic

    Oct 1, 2017, 00:00

  • Lifetime Risk of Revision Following Joint Replacement- Evidence From Routinely-Collected Data

    Oct 1, 2017, 00:00

  • Applicability Of The EQ-5D-3L Descriptive System To Explore Subjective Future Health Expectations

    Oct 1, 2017, 00:00

  • Real-World Utilization Of Blinatumomab In Acute Lymphoblastic Leukemia In The US

    Oct 1, 2017, 00:00

  • Compendium Of Methods For Measuring Patient Preferences In Medical Treatment

    Oct 1, 2017, 00:00

  • Second-Line Treatment for Steroid-Refractory Graft-Versus-Host Disease with Mesenchymal Stromal Cells. A Conceptual Disease Model

    Oct 1, 2017, 00:00

  • An Economic Evaluation Of 'Delivering Assisted Living Lifestyles At Scale’ (DALLAS)

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Avelumab in Patients with Metastatic Merkel Cell Carcinoma in The US

    Oct 1, 2017, 00:00

  • DIABETES MELLITUS ADHERENCE TO CLINICAL FOLLOW-UP, BASED IN LOCAL GUIDELINES AND METABOLICAL OUTCOMES

    Oct 1, 2017, 00:00

  • Real World Data On Labor Procedures In The Brazilian Unified Health System (SUS). An Eight Years Retrospective Database Study

    Oct 1, 2017, 00:00

  • Economic Outcomes Of The Attune® Knee System- Analysis Of Real World Length Of Stay In An Italian Hospital

    Oct 1, 2017, 00:00

  • Comparison of U.S. Hospital Costs Between Transcatheter Aortic Valve Replacement (TAVR) And Surgical Aortic Valve Replacement (SAVR)

    Oct 1, 2017, 00:00

  • Economic Burden Of Herpes Zoster In Spain

    Oct 1, 2017, 00:00

  • Penetration of Peripheral Vascular Interventions in Hungary

    Oct 1, 2017, 00:00

  • Appropriate Diagnosis And Treatment As Key Elements To Improve Health And Rationalize Use Of Resources For Obsessive-Compulsive-Tic-Disorder

    Oct 1, 2017, 00:00

  • Antihypertensive Drug Treatment Prescribed for Essential Hypertension in a Private Hospital in South Sumatra, Indonesia

    Oct 1, 2017, 00:00

  • Health Care Utilization and Costs of Multiple Sclerosis Patients in the Netherlands- A Health Care Claims Database Study

    Oct 1, 2017, 00:00

  • Iso-Osmolar Contrast Media and Adverse Renal and Cardiac Events After Percutaneous Cardiovascular Intervention

    Oct 1, 2017, 00:00

  • Valuing Health At The End Of Life- An Examination Of Framing Effects And Study Design Considerations

    Oct 1, 2017, 00:00

  • Identifying Cost Effective Methods of Health Technology Assessment for Developers – The Need for Fast and Frugal Evaluation

    Oct 1, 2017, 00:00

  • Lower Anterior Resection Surgical Complications In Colorectal Cancer Patients- Association With Length of Stay, Discharge To Institutional Care, And 90-Day Readmission

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib and Erlotinib as Second-Line Treatments for Advanced Squamous Cell Carcinoma of The Lung in China

    Oct 1, 2017, 00:00

  • The Impact Of Modifying Factors On Icer For Pharmaceutical Reimbursement Recommendations In Korea Over 10 Years

    Oct 1, 2017, 00:00

  • The Equivalence Between The Malay And U.S. English Versions Of Rand 36-Item Health Survey 1.0

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison- An Analysis Based on All Pivotal Phase 3 Clinical Trial Data

    Oct 1, 2017, 00:00

  • Patient Characteristics And Reasons for Biologic Monotherapy In Eu5 Markets In Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Metformin Extended Versus Immediate Release In Saudi Arabia- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Impact of Comorbid Critical Limb Ischemia And Diabetes on Healthcare Resource Use And Costs

    Oct 1, 2017, 00:00

  • Network Meta-Analysis of Hazard Ratios vs. Fractional Polynomials Approach in a Cost-Effectiveness Analysis Considering Advanced Gastric Cancer

    Oct 1, 2017, 00:00

  • Budget-Impact-Analysis of Iron Treatment using Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in Austria

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Neonatal Screening With Pulse Oximetry For The Detection of Critical Congenital Heart Disease In Colombia, 2017

    Oct 1, 2017, 00:00

  • Minimizing Bias In Parametric Survival Analyses Of Published Kaplan-Meier Curves

    Oct 1, 2017, 00:00

  • Non-Persistence Risk And Health Care Resource Utilization of Italian Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Calibration Approach Impact on Health and Cost-Effectiveness Outcomes in a Decision Analytic Framework

    Oct 1, 2017, 00:00

  • Economic Burden Of Herpes Zoster (“CULEBRILLA”) In Latin America

    Oct 1, 2017, 00:00

  • Adjusting for Treatment Switching in the Relapsing-Remitting Multiple Sclerosis Clarity Trial and the Clarity Extension Study

    Oct 1, 2017, 00:00

  • 90-Day Mortality and Its Predictors In Women With Contralateral Hip Fracture After Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • Pro Labeling in Products Approved by the European Medicines Agency (EMA) for Narcolepsy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Opioid Substitution Treatment In Republic of South Africa

    Oct 1, 2017, 00:00

  • Comparative Effectiveness Study Of A New Bayesian's Causal Inference Method

    Oct 1, 2017, 00:00

  • Health Care Utilization Associated With Polypharmacy In Patients With Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Medication Related Quality of Life Among Ethiopian Elderly Patients with Polypharmacy- The Case of North Gondar Zone

    Oct 1, 2017, 00:00

  • Is It Cost-Effective To Vaccinate Patients With Acute Coronary Syndrome Against Influenza Virus?

    Oct 1, 2017, 00:00

  • Medical Treatments for Acromegaly- Systematic Review and Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Utility Elicitation for Allergic Rhinoconjunctivitis and Asthma in Children

    Oct 1, 2017, 00:00

  • Polypharmacy And Interactions - What Is A Pharmacist Role?

    Oct 1, 2017, 00:00

  • Divergence of Evaluation of Orphan Drugs Between Regulators and Payers- Implications For Patient Access In US And EU

    Oct 1, 2017, 00:00

  • Burden of Diabetic Foot Ulcers in India- Evidence Landscape from Published Literature

    Oct 1, 2017, 00:00

  • Assessment Of Innovative Medical Devices- Proving The Benefit For The Patient – Best Practices From Germany And France

    Oct 1, 2017, 00:00

  • Development Of An Specific Evaluation Framework For Orphan Drugs Based On Multi-Criteria Decision Analysis (MCDA) For Health Care Decision Making In Catalonia

    Oct 1, 2017, 00:00

  • Knowledge, Attitudes and Perceptions of Ketamine Use by Medical Practitioners in South Africa

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients Argentina

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns in Stage IV Non-Squamous Non-Small Cell Lung Cancer in Argentina

    Oct 1, 2017, 00:00

  • Increasing Clinical Data Quality Through Interactive Data Visualization

    Oct 1, 2017, 00:00

  • Impact Of Adenoma Surveillance Guidelines On The Future Demand Of Colonoscopies Associated To A Population-Based Colorectal Cancer Screening Program

    Oct 1, 2017, 00:00

  • Aging Of Health Care Professionals In Hungary

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Selexipag For The Treatment Of Pulmonary Arterial Hypertension (PAH) In Greece

    Oct 1, 2017, 00:00

  • Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016

    Oct 1, 2017, 00:00

  • What Is The Scope And Quality of Economic Evidence Available for Atopic Eczema? A Systematic Review

    Oct 1, 2017, 00:00

  • Montecarlo Model As A Tool In Estimation of Economic Burden of A Disease Through The Prediction of Biological Characteristics of Tumor In Breast Cancer

    Oct 1, 2017, 00:00

  • Comparison of Early Scientific Advice Processes In UK, France And Germany (HTA ONLY)- Tips And Tricks

    Oct 1, 2017, 00:00

  • Prevalence and Antimicrobial Sensitivity of Salmonella from Fecal and Milk Samples of Lactating Cows, Debre-Zeit, Ethiopia

    Oct 1, 2017, 00:00

  • A Comparative Study on the Effect of Varee Vidaryadi Kashayam and Brihathyadi Kashayam in Lower Urinary Tract Infection

    Oct 1, 2017, 00:00

  • The Burden Of Ad In French Adult Patients- A Multicentric Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Glycemic Control of Adult Type 2 Diabetes Mellitus Patients In The Netherlands- A Cross-Sectional Real World Database Study

    Oct 1, 2017, 00:00

  • Hearth Failure (HF) In Apulia Region - Italy (Local Health Unit Barletta – Andria – Trani)- Analysis Of The Therapeutic Pathways And Related Healthcare Consumption

    Oct 1, 2017, 00:00

  • Atopic Dermatitis Is Associated With Poor Quality of Life In Adult Patients

    Oct 1, 2017, 00:00

  • Adaptation of International Cost-Effectiveness Analyses To A Single Country - The Case of Bariatric Surgery Versus Conventional Treatment For Obesity And Overweight

    Oct 1, 2017, 00:00

  • Conceptual Model and Instrument Review in Multiple Sclerosis

    Oct 1, 2017, 00:00

  • El Impacto Económico De La Comorbilidad En Un Sistema De Salud Privado En México

    Oct 1, 2017, 00:00

  • Formulações Lipídicas De Anfotericina B- Simulação De Custo Com Dados De Mundo Real

    Oct 1, 2017, 00:00

  • Cost-Of-Illness Analysis For Lymphoedema In A Regional Hospital In East Bohemia

    Oct 1, 2017, 00:00

  • Identifying Attributes of Cancer Treatments- What Do Stakeholders Consider Important?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Empagliflozin In The Treatment Of T2d With Previous Cardiovascular Disease In Italy

    Oct 1, 2017, 00:00

  • Survival Differences In Heart Failure Patients With And Without Iron Deficiency/Anemia And By Oral And Intravenous Iron Treatment

    Oct 1, 2017, 00:00

  • Work Productivity in HER2 Positive Breast Cancer- A Comparison of Patients Across Stages of Early and Metastatic Disease

    Oct 1, 2017, 00:00

  • Cost-Benefit Analysis of A Smoking Cessation Program Funded By The Spanish National System In Pre-Operative Patients

    Oct 1, 2017, 00:00

  • Interim Results of A Multi-Country Survey to Evaluate Productivity Loss and Indirect Costs after Cardiovascular Events in Europe

    Oct 1, 2017, 00:00

  • Evidence Map of Cost-Benefit, Cost-Effectiveness and Cost-Utility Models In Dementia Published Since 1960

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Comparison Between Biobrane and Suprathel for Partial Thickness Burn Treatment for Austria

    Oct 1, 2017, 00:00

  • Health Related Quality OF Life Standards in Patients with Parkinson

    Oct 1, 2017, 00:00

  • Estimating Population Trends In Colorectal Cancer Stratified By Stage, Line of Therapy, And High Microsatellite Instability In The United States From 2017 To 2021

    Oct 1, 2017, 00:00

  • Comparative Analysis Of Medicine's Purchassing Prices Of "Additional List"(Aphp Versus French Hospitals Formely Under Overall Allocation)

    Oct 1, 2017, 00:00

  • EVALUATION OF SMOKING PREVALENCE AND ITS ASSOCIATED FACTORS AMONG THE DIABETICS IN PAKISTAN

    Oct 1, 2017, 00:00

  • A Review of Clinical Outcome Assessment Labeling in Europe and in the United States (2013-2016)

    Oct 1, 2017, 00:00

  • “Appraising the appraisers”- Do National Health Technology Assessment Agencies (NICE, GBA/IQWIG) Follow Their Official Evaluation Criteria?

    Oct 1, 2017, 00:00

  • Cetuximab in The Treatment of Mcrc Liver Limited Disease- A Systematic Review

    Oct 1, 2017, 00:00

  • How To Sample Ordered Parameters In Probabilistic Sensitivity Analysis

    Oct 1, 2017, 00:00

  • Treatment Patterns for RA Patients in Italian Real Practice

    Oct 1, 2017, 00:00

  • Estimation of Indirect Costs of The Children Viral Acute Intestinal Infections Therapy in Ukraine

    Oct 1, 2017, 00:00

  • Subgroup Specific Medicine- Finding Patients With Poor Therapy Response

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Treatment Strategies Initiated at Different Stages of Liver Fibrosis for Japanese Patients with Chronic Hepatitis C Genotype 1

    Oct 1, 2017, 00:00

  • The Implications of Vaccine Characteristics and Private-Sector Vaccination on Varicella; A Model-Based Analysis for Mexico

    Oct 1, 2017, 00:00

  • Use of Antipsychotics And The Risk of Colorectal Cancer- A Case-Control Study Using Data From The Linked Netherlands Cancer Registry And Pharmo Database Network Population

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Long-Acting Recombinant FSH (Corifollitropin Alfa) Versus Recombinant FSH (Follitropin Alfa) In Assisted Reproduction Techniques in the Management of Infertility in Iran

    Oct 1, 2017, 00:00

  • 12 Month Review of Nice and SMC Recommendations for New Technologies

    Oct 1, 2017, 00:00

  • Evaluation Of Health-Related Quality Of Life Among Malaysian Non Dialysis Dependent Chronic Kidney Disease Patients

    Oct 1, 2017, 00:00

  • Potential Savings Achieved Through Switching COPD Patients from ICS-Containing Regimens to LAMA-LABA- A Dutch Perspective

    Oct 1, 2017, 00:00

  • Tissue/Site Agnostic Regulatory Approval of Oncology Drugs- Are Htas Ready For A New Era In Personalised Medicine?

    Oct 1, 2017, 00:00

  • Estimating The Proportion of Patients Diagnosed with Allergic Rhinitis, at Risk of Developing Asthma

    Oct 1, 2017, 00:00

  • The Italian Answer To Prep Topic- Evidence From A Multi-Centre HTA Study

    Oct 1, 2017, 00:00

  • Quality of Life In Patients With Lyme Disease In Slovak Republic

    Oct 1, 2017, 00:00

  • Patient Preferences In The Treatment of Periodontal Disease- Multi-Dimensionality and Validity

    Oct 1, 2017, 00:00

  • Pooled Real World Databases Analysis of Patient’s Reported Outcomes In Rheumatoid Arthritis Patients

    Oct 1, 2017, 00:00

  • Does the Distance to the Nearest Pharmacy Affect Medication Adherence Rates Among Elderly Patients with Diabetes?

    Oct 1, 2017, 00:00

  • Bisphosphonates for Osteoporosis Treatment- A Cost-Effectiveness Analysis in Vietnamese Woman

    Oct 1, 2017, 00:00

  • Exploration Of Run-Time Requirements In Probabilistic Sensitivity Analysis Utilizing A Patient Level Based Type 2 Diabetes Simulation Model

    Oct 1, 2017, 00:00

  • Adherence Issues in Diabetes Treatment- How can Acceptance Measurement Help Understanding Patients’ Concerns and Working on Solutions?

    Oct 1, 2017, 00:00

  • Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany- A Population-Based Modelling Study

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis (CUA) of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in the Brazilian Early Breast Cancer Patients

    Oct 1, 2017, 00:00

  • Treatment Patterns In Non-Small Cell Lung Cancer In France

    Oct 1, 2017, 00:00

  • Comparative Assessment of Latin American HTA Appraisals for Oncology

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Using Temocillin, A Narrow-Spectrum Antibiotic, As An Alternative To Broad-Spectrum Carbapenems

    Oct 1, 2017, 00:00

  • Association Of Multiple Chronic Conditions With Health-Related Quality Of Life And Physical Functioning

    Oct 1, 2017, 00:00

  • Early Access Programs; A Useful Tool to Improve Access for Patients and Manufacturers

    Oct 1, 2017, 00:00

  • Prospective Observational Study on Spontaneous Reporting of Adr On Geriatric Population

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis Of Transcatheter Aortic Valve Implantation In France

    Oct 1, 2017, 00:00

  • Relapsing-Remitting Multiple Sclerosis Patients On Dimethyl Fumarate Reported Less Physical And Psychological Disease Impact In The Real World Compared With Patients On Platform Therapies

    Oct 1, 2017, 00:00

  • Use Of Pragmatic Clinical Trials To Support Drug Launch

    Oct 1, 2017, 00:00

  • The Direct Cost of Patients With Multiple Sclerosis In France

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Screening For Severe Combined Immunodeficiency (SCID) In The UK NHS Newborn Bloodspot Screening Programme

    Oct 1, 2017, 00:00

  • Tools For Improving Efficiency In Clinical Management And Safety Of Hypertensive Patients. Efigie-hta Project

    Oct 1, 2017, 00:00

  • Clinical Drivers Of Economic Models And Utility Mapping Algorithms In Schizophrenia

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino (CCU) EN EL Sector Privado De Argentina

    Oct 1, 2017, 00:00

  • Reevaluating A 10 Year Cost-Effectiveness Analysis (CEA) Of The Diabetes Prevention Program Outcomes Study (DPP/DPPOS)- Clarifying The Previous Confusion

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Secukinumab use Versus Tnf-Α Inhibitors, in Patients with Ankylosing Spondilytis

    Oct 1, 2017, 00:00

  • The Clinical Burden Of Bladder Cancer To The Brazilian Society

    Oct 1, 2017, 00:00

  • The Analysis of The Relation Between The Duration of Administrative Procedures And The Methodological Accuracy And Reviewability As Well As The Results of The Submitted Pharmacoeconomic Analyses

    Oct 1, 2017, 00:00

  • The Relationship of Quality of Life and Complete Psoriasis Clearance Over Time – Analyses From Brodalumab Trial Datasets

    Oct 1, 2017, 00:00

  • Cost-Savings Due To Implementation of A Screening Algorithm For Diagnosis of Rheumatoid Arthirits in Colombia

    Oct 1, 2017, 00:00

  • An Economic Model To Estimate The Direct Economic Value Of Reducing The Severity Of Sepsis In French And Us Hospitals

    Oct 1, 2017, 00:00

  • A Review of The Approaches Used To Model Subsequent Treatments In Nice Economic Evaluations- Examples Within Multiple Myeloma And Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Two Long-Acting Muscarinic Antagonists For Copd Treatment In Spain- Umeclidinium VS. Tiotropium (HO-17-18472)

    Oct 1, 2017, 00:00

  • Generating Patient Insights In Dry Eye Disease With A Social Media Listening Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of a Knee Implants Standardization Model in Tertiary Hospitals

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Guided Internet-Based Treatments for Depression In Comparison With Control Conditions- An Individual-Participant Data Meta-Analysis

    Oct 1, 2017, 00:00

  • Impact of Ocrelizumab Vs. Interferon Beta-1a In Delaying The Deterioration Of Patients' Daily Functions and Associated Costs In Relapsing-Remitting Multiple Sclerosis

    Oct 1, 2017, 00:00

  • The use of Scientific Evidence to Support Judicial Decisions

    Oct 1, 2017, 00:00

  • Fair Pricing Of Orphan Drugs In Relation To Additional Health Gains And Disease Prevalence

    Oct 1, 2017, 00:00

  • Estimation of the Budget Saving Potential Due to the Introduction of an Etanercept Biosimilar (SB4) for the Treatment of Approved Adult Etanercept Indications in Belgium

    Oct 1, 2017, 00:00

  • The Most Common Occupational Illnesses Of Medical- And Sports Masseurs

    Oct 1, 2017, 00:00

  • Análisis De Costo Efectividad Del Uso De Budesonida/Formoterol Frente A Salmeterol/Fluticasona, En Pacientes Con Asma Moderada Y Severa En Colombia

    Oct 1, 2017, 00:00

  • O Aumento Da Produção Científica E A Importância Da Biblioteconomia

    Oct 1, 2017, 00:00

  • The Impact of Biosimilar Launch on Molecule Price and Pharmaceutical Expense- The Case of the Insulin Glargine in Italy

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis (CEA) of Nivolumab in 2nd Line Non-Small Cell Lung Cancer (NSCLC) with Non-Squamous Histology (NSQ) Using A Mixed Comparator of Docetaxel and Pemetrexed in An Australian Setting

    Oct 1, 2017, 00:00

  • Methodological Analyses Of Budget Impact Models Submitted To The Haute Autorité De Santé (HAS) (French National Authority For Health)

    Oct 1, 2017, 00:00

  • Comparison of Incremental Cost-Utility Ratios And Sales of Direct Oral Anticoagulants Across Eu-5 Countries

    Oct 1, 2017, 00:00

  • Real-World Evidence on Clinical use of a Novel Oral Anticoagulant for the Treatment of Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Hospital Resource Use in Metastatic Castration Resistant Prostate Cancer (MCRPC) in National University Hospitals in Japan

    Oct 1, 2017, 00:00

  • Alternative Sources For Health Care Funding- Public Health Taxes In Hungary Between 2011-2016

    Oct 1, 2017, 00:00

  • Association of Health-Related Quality of Life (HRQOL) and Healthcare Resource Utilization (HCRU) in Checkmate 141, A Phase 3 Study of Nivolumab Versus Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refrac ...

    Oct 1, 2017, 00:00

  • Annual Economic Comparison of Prophylactic Treatment of Severe Haemophilia A In Spain

    Oct 1, 2017, 00:00

  • Economic Evaluation of Dasatinib Compared To Nilotinib as Second Line Treatment of Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • Comparison Of Hospital Resource Utilization Between Elective And Emergent Admissions Among Patients Undergoing Inpatient Colorectal Surgery

    Oct 1, 2017, 00:00

  • Accounting for Capacity Constraints In Economic Evaluations of Stratified Medicine- A Systematic Review

    Oct 1, 2017, 00:00

  • Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia- A Systematic Review

    Oct 1, 2017, 00:00

  • Costo-Efectividad Del Tratamiento De La Artritis Reumatoide (Ar) Temprana- Una Revisión Sistemática

    Oct 1, 2017, 00:00

  • Effectiveness Of Identifying A Cancer Patient In The Hospital Sector In Northern-Norway - Analyses Based On Updated Regional Performance Database

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ibrutinib in Patients with Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England

    Oct 1, 2017, 00:00

  • A Cost-Saving Model Of Nutrition Care Interventions For Malnourished Hospitalized Patients In Colombia

    Oct 1, 2017, 00:00

  • Cost Impact of A Novel Prophylactic Treatment For Haemophilia A Patients With Inhibitors In The UK

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Mexico

    Oct 1, 2017, 00:00

  • The Analysis of the Number of Same-Day Surgery Cases in 2015 in Hungarian Hospitals

    Oct 1, 2017, 00:00

  • Assessment of Knowledge, Attitude and Common Barriers Towards Reporting Adverse Drug Reactions by Public in Malaysia

    Oct 1, 2017, 00:00

  • Pink October in the Social Media- Are We Still (MIS)Guiding the Public?

    Oct 1, 2017, 00:00

  • Various Strategies of Management of Patients With Diabetic Polyneuropathy- Modeling of Clinical Outcomes And Pharmacoeconomic Analysis

    Oct 1, 2017, 00:00

  • Using An Instrumental Variable Approach To Estimate Causal Treatment Effects In An Observational Cohort of Patients With Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Brazil And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Impact of Disease Activity Measures and Patient Characteristics on Health Utilities in RMS

    Oct 1, 2017, 00:00

  • Efecto Del 1B8 EN EL Tratamiento De Pacientes Con Linfoma No Hodgkin Cd20+

    Oct 1, 2017, 00:00

  • Pricing And Time-To-Market For Monoclonal Antibodies In Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Study of the use of Portable Coagulometers for the INR Control, In Comparison with Hospital Care, In Patients with Coagulation Disorders, Under the Context of the Mexican Public Health Setting

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Rivaroxaban VS Vitamin K Antagonist In Routine Care Patients Treated For Non-Valvular Atrial Fibrillation In Germany – A Renal Impairment Subgroup Analysis

    Oct 1, 2017, 00:00

  • Assessing The Cost Effectiveness Of A New, First-In-Class Triple Fixed Dose Combination Therapy For COPD Patients

    Oct 1, 2017, 00:00

  • Cost Per Response Analysis of Nivolumab Versus Everolimus in the Treatment of Patients Previously Treated with Advanced Renal Cell Carcinoma – Brazil Private Health Care System Perspective

    Oct 1, 2017, 00:00

  • Message from Co-Editors

    Oct 1, 2017, 00:00

  • Overcoming the Limitations of Claims Data- Linkage of Claims Data with Secondary Data Sources in Germany

    Oct 1, 2017, 00:00

  • A Systematic Review of Comparative Effectiveness of Ezetimibe And PCSK9 Inhibitors

    Oct 1, 2017, 00:00

  • A Cross Section Study on Prevalence of Neuro-Psychiatric Disorders and Quality of Life in Post Stroke Patients

    Oct 1, 2017, 00:00

  • Robotic Oncological Surgery Program Evaluation Using A Logic Model

    Oct 1, 2017, 00:00

  • Cost Model for a New Acoustic Diagnostic AID to Rule Out Coronary Artery Disease

    Oct 1, 2017, 00:00

  • Dialysis Status In Patients With Chronic Kidney Disease In Korea- Based On 12-Years National Sampel Cohort Database

    Oct 1, 2017, 00:00

  • A Three Month Interim Analysis of Treatment Satisfaction with Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis in the UK- The Patient Reported Outcomes with Fingolimod in Local Experience (Profile) Study

    Oct 1, 2017, 00:00

  • The Greta Study- Generating Real-World Evidence about Bevacizumab Treatment of Metastatic Colorectal Cancer by Linking Cancer Registries and Healthcare Databases in Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nilotinib Versus Dasatinib for The Second-Line Treatment of Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (CML-CP), Resistant or Intolerant To Imatinib, in Frame of Russian He ...

    Oct 1, 2017, 00:00

  • Annual Costs of Best Supportive Care for Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) in Germany

    Oct 1, 2017, 00:00

  • Conceptualization, Development, And Internal And External Validation of A ‘Whole Disease’ Model for Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Implementing Managed Entry Agreements in Practi The Dutch Reality Check

    Oct 1, 2017, 00:00

  • Expected Value of Sample Information For Individual Level Simulation Models To Inform Stop/Go Decision Making By Public Research Funders- A Methodology for The Dafneplus Diabetes Education Cluster Rct

    Oct 1, 2017, 00:00

  • Resource Allocation For Treating Alcohol And Drug Misuse In Psychosocial Care Center In Brazil- Is Current National Funding Enough For Covering Its Total Costs?

    Oct 1, 2017, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C- A Decision Analysis from The Perspective of The Brazilian Public Health System

    Oct 1, 2017, 00:00

  • The Clinical Burden Of Head And Neck Cancer To The Brazilian Society

    Oct 1, 2017, 00:00

  • Lack Of Standardized Methods For Handling Multiples Sources For Model Parameters- A Systematic Review

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of Tacrolimus XL in Comparison to Generic Tacrolimus from the Public Healthcare Sector in Mexico

    Oct 1, 2017, 00:00

  • Impact Of Weight Change After Quitting Cigarettes On All-Cause And Cause-Specficic Mortality In Middle-Aged Male Smokers- National Health Screening Cohort Study

    Oct 1, 2017, 00:00

  • Evaluating Adverse Events Costs in Cancer Patients in Lebanon From Two Payers Perspective

    Oct 1, 2017, 00:00

  • Burden of Moderate to Severe Depression in the US Adult Population

    Oct 1, 2017, 00:00

  • Women's Preferences- A Discrete-Choice Experiment For Treatment of Menorrhagia with Uterus-Preserving Therapy

    Oct 1, 2017, 00:00

  • The Economic Burden Of Congenital Cytomegalovirus-Related Hospitalizations In The United States

    Oct 1, 2017, 00:00

  • Roche Oncology Data in Open Access- An Innovative Step for Scientists

    Oct 1, 2017, 00:00

  • Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc)- Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Stud ...

    Oct 1, 2017, 00:00

  • Assessing The Cost-Effectiveness Of The Manchester Acute Coronary Syndrome (MACS) Decision-Aid- A Feasibility Study

    Oct 1, 2017, 00:00

  • Use Of Healthcare Resources And Associated Costs Of Idiopathic Pulmonary Fibrosis In Spain- A Real-Life Study

    Oct 1, 2017, 00:00

  • Economic Evaluation of New HCV Treatments in Egypt

    Oct 1, 2017, 00:00

  • Daily Living With Early Retinal Diseases- The Patient Perspective

    Oct 1, 2017, 00:00

  • The Impact Of Cancer Drugs Fund Reforms On Reimbursement Of Oncology Drugs In The UK

    Oct 1, 2017, 00:00

  • A Comparison Of Antiretroviral Drugs Approved In The US And Europe In The Period 1987-2015

    Oct 1, 2017, 00:00

  • Analysis of Recent Approvals of Immuno-Oncology Drugs Across England, Scotland, Germany And France

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66 (current)
  • 67
  • 68
  • 69
  • 70
  • »